Biomarkers of kidney disease

Clinical applications for biomarkers include monitoring illness activity, diagnosing it, managing molecularly targeted therapies, and monitoring therapy response. Glomerular filtration rate (GFR) continues to be the ideal indicator of renal health. Kidney damage atoms and lipocalin associated with neutrophil gelatinase are thought to be useful biomarkers in plasma and urine to assess the severity and prognosis of Chronic Kidney Disease.

  • Decompensated heart failure

Related Conference of Biomarkers of kidney disease

May 26-27, 2025

29th European Nephrology Conference

Rome, Italy
June 23-24, 2025

14th International Conference on Nephrology & Therapeutics

Aix-en-Provence, France
August 28-29, 2025

10th World Kidney Congress

London, UK
March 26-27, 2026

22nd World Nephrology Conference

Amsterdam, Netherlands

Biomarkers of kidney disease Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in